Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)

CUSIP: 61225M102

Q4 2024 13F Holders as of 31 Dec 2024

Security identity
Shares outstanding
84,039,109
Holder snapshot
Share change
+11,215,580
Put/Call ratio
5.8%
Reported price per share
$6.94
Number of holders
104
Value change
+$79,110,231
Number of buys
64
Number of sells
28

Security key

61225M102

Report period

Q4 2024

Institutions

104

Top holders

10

Ownership snapshot

Top reported holders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
15
Latest as of
31 Dec 2024
13D/G 13F Lead comparable stake: 6.3% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
6.3%
$20,045,661
3,840,165 shares
$0 31 Dec 2024
NEA Management Company, LLC
13F
Company
13F
9.2%
$40,769,179
7,692,298 shares
30 Sep 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
7.9%
$34,987,000
6,601,141 shares
30 Sep 2024
Avoro Capital Advisors LLC
13F
Company
13F
6.9%
$30,688,251
5,790,236 shares
30 Sep 2024
FMR LLC
13F
Company
13F
6.1%
$27,037,489
5,101,413 shares
30 Sep 2024
BAKER BROS. ADVISORS LP
13F
Company
13F
5.8%
$26,055,304
4,916,095 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
104
Shares
60,988,332
Rows available
104
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
80
Q4 2024 holders
104
Holder diff
24
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .